drugset / Trial / NCT05501327
Dose Regimen Study of SLI-F06 in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
Multi-center, dose-regimen, double-blind study evaluating the safety and efficacy of 4 doses of SLI-F06 compared with vehicle for improvement in scar appearance
Timeline
- Start
- 2022-07-25
- Primary completion
- 2024-07-25
- Completion
- 2024-10-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SLI-F06 | Unknown | 3.75 mg | Other |
| Subject | SLI-F06 | Unknown | 7.5 mg | Other |
| Subject | SLI-F06 | Unknown | 15 mg | Other |
Indications
No indication recorded.